Activation of the nociceptin/orphanin FQ system is unable to reverse CRF2 receptor mediated anorexia in the rat

Peptides. 2006 Dec;27(12):3284-91. doi: 10.1016/j.peptides.2006.09.001. Epub 2006 Oct 16.

Abstract

Central injection of Nociceptin/Orphanin FQ (N/OFQ), inhibits the anorectic effect of corticotropin-relasing factor (CRF) and stress in rats. Recently, Urocortin II (Ucn II) and Urocortin III (Ucn III), two selective CRF(2) receptor agonists, have been identified. Here, we investigated the effect of intracerebroventricular (ICV) injection of 0.25, 0.75, 1.50 or 3 nmol/rat of Ucn II or Ucn III on food and water intake in food deprived rats. The effect of N/OFQ on Ucn II and UCNIII-induced anorexia was also studied. Results showed a greater inhibition of food consumption by Ucn II than Ucn III. Pretreatment with N/OFQ (0.25-2.0 nmol/rat) did not block the effects of Ucn II and UCNIII. Conversely, injection of N/OFQ (0.25-2.0 nmol/rat) blocked the anorectic effect of CRF (0.1 nmol/rat). These findings suggest that N/OFQ selectively prevent the anorectic effect mediated by activation of the CRF(1) receptor system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anorexia / metabolism*
  • Drinking / physiology
  • Injections, Intraventricular
  • Male
  • Nociceptin
  • Opioid Peptides / physiology*
  • Rats
  • Rats, Wistar
  • Receptors, Corticotropin-Releasing Hormone / physiology*
  • Urocortins / administration & dosage
  • Urocortins / physiology

Substances

  • CRF receptor type 2
  • Opioid Peptides
  • Receptors, Corticotropin-Releasing Hormone
  • Urocortins